These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36219086)

  • 1. [Substitution treatments for opiate-dependent users. An experience of the Integrated Addiction Treatment Center in Dakar].
    Gaye S; Malissin I; Gadji M; Thiam MH; Mégarbane B
    Med Sci (Paris); 2022 Oct; 38(10):832-837. PubMed ID: 36219086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
    Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
    Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U; Haasen C; Reimer J
    Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors impeding switching from methadone to buprenorphine in heroin users receiving methadone maintenance therapy - A naturalistic cohort study.
    Chung KS; Wu HC; Hsu CY; Lu YS; Li DJ
    J Subst Abuse Treat; 2019 Oct; 105():51-56. PubMed ID: 31443892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and associated factors of heroin-dependent patients receiving methadone and buprenorphine maintenance treatment.
    Chang HM; Huang MC; Fang SC; Lin SK
    Neuropsychopharmacol Rep; 2023 Dec; 43(4):607-615. PubMed ID: 38088122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
    Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
    Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing need for medication-assisted treatment for opiate-dependent prison inmates.
    Albizu-García CE; Caraballo JN; Caraballo-Correa G; Hernández-Viver A; Román-Badenas L
    Subst Abus; 2012; 33(1):60-9. PubMed ID: 22263714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.
    Oviedo-Joekes E; Nosyk B; Marsh DC; Guh D; Brissette S; Gartry C; Krausz M; Anis A; Schechter MT
    Clin Trials; 2009 Jun; 6(3):261-71. PubMed ID: 19528135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological maintenance treatments of opiate addiction.
    Bell J
    Br J Clin Pharmacol; 2014 Feb; 77(2):253-63. PubMed ID: 23210630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reimbursement of opiate substitution drugs to militaries in 2007].
    d'Argouges F; Desjeux G; Marsan P; Thevenin-Garron V
    Encephale; 2012 Sep; 38(4):304-9. PubMed ID: 22980471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments].
    Lepère B; Gourarier L; Sanchez M; Adda C; Peyret E; Nordmann F; Ben Soussen P; Gisselbrecht M; Lowenstein W
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS5-12. PubMed ID: 11435989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer attitudes about opioid addiction treatment: a focus group study in New York City.
    Sohler NL; Weiss L; Egan JE; López CM; Favaro J; Cordero R; Cunningham CO
    J Opioid Manag; 2013; 9(2):111-9. PubMed ID: 23709320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood.
    Leventelis C; Goutzourelas N; Kortsinidou A; Spanidis Y; Toulia G; Kampitsi A; Tsitsimpikou C; Stagos D; Veskoukis AS; Kouretas D
    Oxid Med Cell Longev; 2019; 2019():9417048. PubMed ID: 31093318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study.
    Nava F; Manzato E; Leonardi C; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1867-72. PubMed ID: 18801404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heroin maintenance for chronic heroin-dependent individuals.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003410. PubMed ID: 20687073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.